BioInfra Co., Ltd. (KOSDAQ: 199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,760.00
-220.00 (-3.15%)
Dec 20, 2024, 9:00 AM KST
-41.57%
Market Cap 32.43B
Revenue n/a
Net Income n/a
Shares Out 4.80M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date Dec 27, 2024
Volume 13,621
Open 6,910.00
Previous Close 6,980.00
Day's Range 6,670.00 - 7,010.00
52-Week Range 5,660.00 - 12,930.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About BioInfra

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

News

There is no news available yet.